|Articles|January 1, 2018
- Pharmaceutical Executive-01-01-2018
- Volume 38
- Issue 1
Pharmaceutical Executive, January 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Changing Skies: Pharm Exec’s 2018 Industry Forecastalmost 8 years ago
Q&A: From Gleevec to CAR-Talmost 8 years ago
Prices and Competition to Shape the Year Aheadalmost 8 years ago
CAR-T Concerns for Continued Successalmost 8 years ago
New Year, Next Steps in Digital Transformationalmost 8 years ago
Food for Thought in Cancer Fightalmost 8 years ago
Parting Arrangementsalmost 8 years ago
Country Report: SwitzerlandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
